With respect to Insite, the Safe Injection Site (SIS): (a) what studies and evaluations about safe injection sites have been undertaken, requested or commissioned by Health Canada; (b) what individuals, what department or what organization undertook these studies; (c) what is the cost of these studies; (d) what are the findings and recommendations of these studies; (e) what recommendations does the government agree with; (f) what studies and evaluations have been requested or commissioned by Health Canada to be undertaken before December 31, 2007; (g) what Heath Canada studies, reports and recommendations have already been presented to the government prior to September 2006; and (h) what amount of funding has the government provided directly, or indirectly, to SIS?
In the House of Commons on November 22nd, 2007. See this statement in context.